Difference between revisions of "Talk:2011 Group Project 10"

From Embryology
Line 5: Line 5:
  
 
==Peer Review==
 
==Peer Review==
 +
 +
'''Group 10 Peer assessment'''
 +
*Heading order needs to re-arranged and done properly with diagnosis above before signs and symptoms.
 +
*Introduction done sort of well needs to integrate image as an example of the myofibres.
 +
*History rather bulky with too much text and no image, image of the founder would be fine. Also no time line present of DM needs to be added
 +
*Epidemiology seems rather empty, images would benefit this section also more stats, further expansion of sub headings would also do well for this section
 +
*Genetics aetiology needs to be expanded where seems to be cramped, though usage of image needs to be noted
 +
*Pathogenesis needs images and further information
 +
*Signs and symptoms needs to be expanded and image of some signs or tables
 +
*Clinical manifestation done well with image and further sub-headings
 +
*Diagnosis requires more attention with further methods of detection of DM
 +
*Treatment is well done with the usage of the table
 +
*Glossary needs to further expanded also linked to the pages so easy to follow the page
 +
*References are not complete with links and repeats of the references
 +
z3332250 23:59, 26 September 2011 (EST)
 +
 +
 
'''Group 10  Critique'''
 
'''Group 10  Critique'''
  

Revision as of 00:59, 27 September 2011

Group 10: User:z3332327 | User:z3332629 | User:z3332824 | User:z3330313

Plagiarism

--Mark Hill 07:35, 30 September 2011 (EST) Currently all students originally assigned to each group are listed as equal authors/contributors to their project. If you have not contributed the content you had originally agreed to, nor participated in the group work process, then you should contact the course coordinator immediately and either discuss your contribution or request removal from the group author list. Remember that all student online contributions are recorded by date, time and the actual contributed content. A similar email reminder will be sent to all current students.

Please note the Universities Policy regarding Plagiarism

In particular this example:

"Claiming credit for a proportion of work contributed to a group assessment item that is greater than that actually contributed;"

Academic Misconduct carries penalties. If a student is found guilty of academic misconduct, the penalties include warnings, remedial educative action, being failed in an assignment or excluded from the University for two years.

2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip



Peer Review

Group 10 Peer assessment

  • Heading order needs to re-arranged and done properly with diagnosis above before signs and symptoms.
  • Introduction done sort of well needs to integrate image as an example of the myofibres.
  • History rather bulky with too much text and no image, image of the founder would be fine. Also no time line present of DM needs to be added
  • Epidemiology seems rather empty, images would benefit this section also more stats, further expansion of sub headings would also do well for this section
  • Genetics aetiology needs to be expanded where seems to be cramped, though usage of image needs to be noted
  • Pathogenesis needs images and further information
  • Signs and symptoms needs to be expanded and image of some signs or tables
  • Clinical manifestation done well with image and further sub-headings
  • Diagnosis requires more attention with further methods of detection of DM
  • Treatment is well done with the usage of the table
  • Glossary needs to further expanded also linked to the pages so easy to follow the page
  • References are not complete with links and repeats of the references

z3332250 23:59, 26 September 2011 (EST)


Group 10 Critique

  1. • The introduction was very good. Good use of images to give it a little decoration!
  2. • History is good
  3. • Epidemiology is good, however if possible try and make it longer/ include more information
  4. • The Genetics section is a bit too short. Add more information. Good hand drawn image!
  5. • Pathogenesis is a little short. Needs more information
  6. • Signs and Symptoms is good
  7. • Clinical manifestations is ok
  8. • Diagnosis, treatment and glossary are all well written. These sections should not require any change

--Robert Klein 16:27, 26 September 2011 (EST)

Group 10 Duchenne Muscular Dystrophy

  • The first paragraph of the introduction has no reference.
  • The paragraphs in history are quite long, often with grammar mistakes, incorrect punctuations and many of the ideas within a sentence separated by a -. For example the second last paragraph within history.
  • The history is too verbose, a timeline with bullet points will look better
  • Aetiology is quite concise and informative however gramatical errors are a distraction. For example There a multiple forms of dystrophin. It might be a good idea to proofread the page.
  • Well done with the student drawn image
  • 'Pathogenesis' is again well written however an image might have given it a balance between the text in the section and the pictures or tables
  • The future therapies table is a little confusing, you might want to add more columns and define the therapy, and then discuss what the challenges and findings are and at the end column finish off with what the implication might be if the research is to be completed successfully. At the moment you have discussed all that in one big paragraph and the way the descriptions start, it sounds like there is no background to the description, just a little abrupt.
  • The glossary is very short and you should include terms like de novo mutation.
  • The existing definitions are unclear and incomplete

Duchenne Muscular Dystrophy

  • Make sure you add a proper heading for the page, so it doesn't just start with 'Introduction'
  • The 'Introduction' is a good start to the page, very easy to read and understand
  • 'History' is a bit difficult to read, try to make is sequential order, or at least bold the dates
  • In 'History' we don't really want a story, but key dates in the history of the discovery of the disorder. Surely something has happened in the past 150 years?
  • Good work with 'Pathogenesis', it is a good description of the development of the disorder
  • Can we see an image relating to the signs and symptoms?
  • 'Clinical Manifestations' is a good thorough description, though I don't understand what going on with the last section 'Smooth Muscle' with the random &&&. It is also a whole lot more general than the preceeding sections. Is it finished?
  • Could you give a bit more detail in 'Diagnosis'. It would be good to explain each method a bit more and explain why they are relevant.
  • Can you expand on the table a bit? ie P188, what exactly is it used for? How does it treat it? How effective is it? When is it administered etc
  • No current research section? This could be a good conclusion to the page - the 'Stem Cell Transplant' section from 'Treatments' would fit better here
  • The glossary needs to be finished and expanded on
  • Overall the page is not bad, but more images are needed and some clarification on topics


Group 10-

  • Need more images to break up the text
  • The introduction was really easy to read and had relevant information in it
  • History should be in bullet point form to make it easier to access or at least have the dates in BOLD
  • Does the history include dates after the 1800s? or did all research stop then?
  • Epidemiology was good. Had all the relevant info
  • Pathogenesis would benefit an image or a diagram
  • Signs and symptoms could be put with clinical manifestations.
  • What is the point of the ‘&&&’? in clinical manifestations and complications?
  • Diagnosis could be expanded upon to explain how and why these methods work
  • Treatment could also be expanded on. A list of drugs doesn’t explain much
  • There is not current/future research section
  • This is a good start to the project but more research needs to be done


Group 10

  • The structure and use of headings and subheadings is good, make sure you title your page.
  • Good info very informative and it gives a good overview to DMD.
  • HIstory has a lot of text could you use a timeline here?
  • i think a picture of the pathogenesis would improve this section.
  • Has your group look at the CNS and cognitive function of DMD boys its a controversial area as many people have different attitudes towards this but Dr Stewart Head a UNSW lecture actually studies DMD and is very informative in the area and recently published a article in the journal Brain.
  • The CNS is highly affected by the lack of dystrophin as well as GABA receptors. I think this area is very import to consider as it highly affects the boys at school.
  • Could you add some pictures to your page or break it up with the use of more tables as it a lot of text in comparison to pictures and tables.
  • Make sure your reference list is not doubled.
  • Ensure all your pictures are referenced properly.
  • Student image is present.
  • This is a good start.

Discussion

GROUP 10!

To make everything easier to follow, we have agreed to write any updates, info, discussion etc at the BOTTOM of this page, it will just stop us having to keep going up and down and wasting time trying to find the information we want.




Hey Everyone,

So Mark went through each group today during the lab and the webpages and discussed where we should be up to. By next week, he expects the subheadings & some content to be up and running. He also recommended that we should have some more research going on in our discussion page. E.g. Research articles links, interesting sites etc.

Topics have been allocated so please begin your research and typing up some content. We can further divide our headings if necessary, take a look at some other groups, they have some pretty good ideas. Mark will be checking this next week during our lab. He'll be coming around to each of us.

So hopefully see you all next week !

--z3332327 12:53, 25 August 2011 (EST)

Subheadings for assignment

Intro what is DMD

History/timeline

Genetic component

Why is it an abnormality - Symptoms effect

Diagnosis, future/current prospect (treatments?)

2 case studies

Glossary of terms

Post online any preferences you may have in terms of the topics you wish to research and by Sunday we will allocate sub topics

--z3332629 13:09, 18 August 2011 (EST)


Okay hey guys just to get the discussion going, umm I don't mind doing the first 2 on the list. And the "Why is it an abnormality - Symptoms effect" sounds pretty interesting as well. What are your preferences?? :)

--z3330313 14:55, 23 August 2011 (EST)

Hey Everyone, Im happy to do the diagnosis/current/future prospects point and a case study.

--z3332327 15:36, 23 August 2011 (EST)

Hello, I would like to do the 'why is it an abnormality - symptoms effect' and then it will be easy to incorporate that with a case study. So I guess that leaves Ashleigh to do the genetic component mostly, but we will ALL help out with that :D How does this sound?

--User:Z3332824 10:22, 25 August 2011 (EST)

Duchenne Muscular Dystrophy - recessive X-linked form of muscular dystrophy, which results in muscle degeneration, difficulty walking, breathing, and death. It is caused by a mutation of the dystrophin gene at locus Xp21.

Osteogenesis Imperfecta - caused by defect in the gene that produces type 1 collagen, an important building block of bone. Most cases of OI are inherited from a parent, although some cases are the result of new genetic mutations. A person with OI has a 50% chance of passing on the gene and the disease to their children.

Congenital Adrenal Hyperplasia - refers to any of several autosomal recessive diseases resulting from mutations of genes for enzymes mediating the biochemical steps of production of cortisol from cholesterol by the adrenal glands (steroidogenesis).

DiGeorge Syndrome - congenital immunodeficiency. Di George syndrome is an inherited condition that lies at the more severe end of a spectrum of syndromes (also known as CATCH22 or 22q11.2 deletion syndrome) that occur when a part of the DNA on chromosome 22 is missing. Several different genes are lost, resulting in a collection of different features, including problems with the immune system, congenital heart defects and abnormalities of the parathyroid glands. z3332327 22:28, 7 August 2011 (EST)

Review Article: Targeting RNA to treat neuromuscular disease. Muntoni, F & Wood, M.J.A. (2011) Nature Reviews Drug Discovery 10, 621-637. http://www.nature.com.wwwproxy0.library.unsw.edu.au/nrd/journal/v10/n8/full/nrd3459.html

Research Article: Ahmad N, Welch I, Grange R, Hadway J, Dhanvantari S, Hill D, Lee TY, Hoffman LM. Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice. BMC Musculoskelet Disord. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141608/pdf/1471-2474-12-127.pdf

z3332327 23:11, 10 August 2011 (EST) ______________________________________________________________________________________________________________________________________________

Friedreich Ataxia – Is caused by defect/mutation of the gene FXN, the disorder is recessive. It is an inherited disease that causes nervous system damage and impaired muscle coordination (ataxia) through spinal cord, peripheral nerve and cerebellum degeneration.

Lesch-Nyhan Syndrome – Rare inherited disorder where there is a deficiency of the enzyme: hypoxanthine-guanine phosphoribosyl transferase (HPRT). This is caused by mutations of the HPRT gene located on the x-chromosome. This disorder is an x-linked recession disease, it causes kidney probems (building up of uric acid in all body fluids) and moderate mental retardation.

Farber's Disease – Is an inherited autosomal recessive lysosomal storage disease. The gene responsible making the enzyme ceramidase is mutated. This enzyme breaks down fatty material in the body’s cell. [not recommended to do, limited disease]

Mucopolysaccharidoses – Inherited metabolic disease where a defective or missing enzyme cause large amounts of complex sugar molecules to accumulate in harmful amounts in the bodies cells and tissues. They can’t break down these glycosaminoglycans into smaller chains. It ends up causing progressive cellular damage which affects appearance, physical abilities, organ and system functioning, and, in most cases, mental development.

--z3330313 23:43, 7 August 2011 (EST)

Note - This page is an undergraduate science embryology student group project 2011.
2011 Projects: Turner Syndrome | DiGeorge Syndrome | Klinefelter's Syndrome | Huntington's Disease | Fragile X Syndrome | Tetralogy of Fallot | Angelman Syndrome | Friedreich's Ataxia | Williams-Beuren Syndrome | Duchenne Muscular Dystrolphy | Cleft Palate and Lip

Hey group 10 members! I've quickly done some research on the top 4 listed disorders. All of them had loads of info!! Let me know what you think and lets say by monday we should pick a topic?

Angelman syndrome - rare neuro-genetic disorder - characterised by severe intellectual disability, speech impediment, sleep disturbance, unstable jerky gait, seizures and usually a happy demeanour - occurs about one in 20,000 births - Severe intellectual disability and developmental delay - Profound speech impairment - Movement for balance disorder

Turner’s syndrome - affects about 1 in every 2,500 girls - usually short in height - born with only one X chromosome or they are missing part of one X chromosome - prevents the ovaries from developing properly - kidney problems, high blood pressure, heart problems, overweight, hearing difficulties, diabetes, and thyroid problems

Williams Syndrome - rare genetic disorder characterized by mild to moderate mental retardation or learning difficulties, a distinctive facial appearance, and a unique personality that combines over-friendliness and high levels of empathy with anxiety. - Common problem: cardiovascular disease caused by narrowed arteries - A random genetic mutation (deletion of a small piece of chromosome 7), rather than inheritance, most often causes the disorder - 50 percent chance of passing it on if they decide to have children

Cystic Fibrosis - Cystic fibrosis (CF) is a recessive genetic disease of the mucus and sweat glands, which affects the entire body. - affects mostly your lungs, pancreas, liver, intestines, sinuses and sex organs - makes it easy for bacteria to grow - Difficulty breathing - multitude of other symptoms, including sinus infections, poor growth, diarrhea, and infertility result from the effects of CF on other parts of the body


--z3332629 14:10, 4 August 2011 (EST)

Sorry i accidently posted it on the actual project page lol


--Ashleigh Pontifex 13:31, 10 August 2011 (EST) Review article: Functional characteristics of dystrophic skeletal muscle: insights from animal models. Jon F. Watchko1, Terrence L. O'Day1, and Eric P. Hoffman2 http://jap.physiology.org/content/93/2/407.long

Research article: The common missense mutation D489N in TRIM32 causing limb girdle muscular dystrophy 2H leads to loss of the mutated protein in knock-in mice resulting in a Trim32-null phenotype Elena Kudryashova1, Arie Struyk2,†, Ekaterina Mokhonova1, Stephen C. Cannon2 and Melissa J. Spencer1,* http://hmg.oxfordjournals.org/content/early/2011/07/28/hmg.ddr311.long --Ashleigh Pontifex 13:31, 10 August 2011 (EST)



Hello! So my four diseases:

1. Fragile X Retardation: males mostly, the code CGG is repeated on a fragile area of the X chromosome. The more repeats, the more problems. See http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002633/ for more details on symptoms etc.

2. Klinefelter Syndrome: extra X chromosome in males - XXY. Abnormal body proportions, infertility, less hair, big boobs, problems with their genitals (poor things). http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001420/

3. Triple X: I think this is a trisomy and should be avoided? It is having XXX in females.

4. Thalassemia: blood disorder in which you have abnormal haemoglobin. Results lead to excessive destruction of RBC which leads to anaemia. Inherited from BOTH parents. Bone deformities in face, fatigue, growth failure, jaundice. See http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001613/


Personally, out of my four I think either Fragile X or Thalassemia will be the most interesting. Angelman Syndrome and Duchenne Muscular Dystrophy also sound cool. I think we should avoid all ones that are really specific biochem disorders (or to that effect)- something like Mucopolysaccharidoses - because we might get bogged down in the details and have to spend ages figuring out what its actually doing.

What is everyone else's thoughts? See you tomorrow, Rhiannon.

I think we should do Duchenne Muscular Dystrophy. --Ashleigh Pontifex 11:03, 11 August 2011 (EST)

I agree ! Lisa Xiao 11:04, 11 August 2011 (EST)

Yes that sounds good, lets do it :) --Joanna Pak 11:38, 11 August 2011 (EST)

Yep, I'm all for it. I'm glad we can bags it before everyone else :D Rhiannon

--Rhiannon Bice 11:40, 11 August 2011 (EST)


Useful Links

[1]National Human Genome Research Institute: Fact Sheet on Duchennes

Treatment

No known cure. However treatment aims to manage symptoms to maximize the quality of life. Treatments includes: - Physical Therapy: in order to maintain muscle strength and function. (Inactivity leads to weakened muscles and can worsen the condition) - Orthopedic appliances such as braces and wheelchairs are available to improve mobility - Aggressive management of dilated cardiomyopathy with anti-congestive medications - The medication prednisone — a steroid — is given to improve the strength and function of individuals with DMD (However there are side affects associated with this medication)

Future Prospects - Gene Therapy

[2]Medline Plus: Encyclopedia

--z3332327 15:48, 16 August 2011 (EST)


Hey guys, I couldn't copy a picture relating to Duchenne, so i just got a random one :) Rhiannon.


File:Patterns of zona pellucida deposition and ZPC-ubiquitin colocalization in porcine ocyte-cumulus complexes isolated from small antral follicles.JPG

Patterns of zona pellucida deposition and ZPC-ubiquitin colocalization in porcine ocyte-cumulus complexes isolated from small antral follicles. [1]

  1. <pubmed>21383844</pubmed>

Flow of participants.JPG

File: Flow of Participants --Lisa Xiao 12:43, 18 August 2011 (EST)

1532-429X-13-20-1.jpg

--z3330313 12:51, 18 August 2011 (EST)

Hey girls its Ashleigh, sorry I've been quite sick over the last week. How about me copy and paste the headings again and write our names next to our bit and we can leave suggests as to what can fit into that heading etc? Ps did I miss anything from last weeks lab??

--Ashleigh Pontifex 19:38, 30 August 2011 (EST)


Official discussion

Subheadings for assignment

Intro what is DMD

History/timeline

Genetic component

Why is it an abnormality - Symptoms effect

Diagnosis, future/current prospect (treatments?)

2 case studies

Glossary of terms

Post online any preferences you may have in terms of the topics you wish to research and by Sunday we will allocate sub topics

--z3332629 13:09, 18 August 2011 (EST)


Just found an awesome website!

http://emedicine.medscape.com/article/1173204-overview

Check it out when you can, it has info on history & treatment as well as some really good images.

File:Point vs frameshift mutations.jpg

Whoever is doing future direction of treatment etc., check out this article on PubMed

Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions.

http://www.ncbi.nlm.nih.gov/pubmed/21674516?tool=MedlinePlus

Abstract

Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy and occurs in 1 in 3500 male births. Improved survival due to improvements in clinical care of the musculoskeletal and respiratory systems has led to an increased incidence of cardiomyopathy. Cardiac-related deaths are now seen in approximately 20% of DMD patients. Our current understanding of DMD cardiomyopathy has increased significantly over the past 10 years, but further research is required to improve cardiac treatment and outcomes in DMD. This review provides a summary of the current literature and discussion of potential new therapies for DMD cardiomyopathy.

Copyright © 2011 Wiley Periodicals, Inc.

--Ashleigh Pontifex 20:00, 30 August 2011 (EST)

Some quick points from: http://ghr.nlm.nih.gov/condition/duchenne-and-becker-muscular-dystrophy

- Mutations in the DMD gene causes DMD

- The DMD gene provides instructions for making a protein called dystrophin that helps stabilize and protect muscle fibers and may play a role in chemical signaling within cells.

- Mutations alter the structure or function of dystrophin, or prevent any functional dystrophin from being produced.

- Muscle cells without this protein become damaged as muscles repeatedly contract and relax with use. The damaged fibers weaken and die over time, leading to the muscle weakness and heart problems characteristic of Duchenne and Becker muscular dystrophies.

- This condition is inherited in an X-linked recessive pattern.

- Males are affected by X-linked recessive disorders much more frequently than females.

- Fathers cannot pass X-linked traits to their sons.

- Females who carry a DMD gene mutation also have an increased risk of developing heart abnormalities including dilated cardiomyopathy.


Hey guys I found this slide show on DMD, quite easy to understand because all u have to do is listen! So its http://hstalks.com.wwwproxy0.library.unsw.edu.au/main/citation_info.php?c=252 Oh and I'm not 100% sure on how to reference properly so bear with me if I make a mistake on the group page. And I'm going to try and borrow some books DMD to see if there's more of an indepth history of the disorder. If u guys feel your part is too big, let me know because I'm willing to help out!!

(http://www.whonamedit.com/doctor.cfm/950.html) --Joanna Pak 02:10, 1 September 2011 (EST)


I've been doing a bit of research and found some good papers.

Rodino-Klapac LR, Chicoine LG, Kaspar BK, Mendell JR. Gene therapy for duchenne muscular dystrophy: expectations and challenges. Arch Neurol. Sep 2007;64(9):1236-41

Bogdanovich S, Perkins KJ, Krag TO. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions. J Mol Med. Feb 2004;82(2):102-15

Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med. Dec 2007;13(12):520-6

AND the a copy of original book by Gower (one of the first to describe the disease etc) is at the library! Its called ' A manual of Diseases of the Nervous System'. Pages 378-393. I will be checking that out tonight or tomorrow. -Rhi.


Treatment: http://emedicine.medscape.com/article/1173204-overview -- Useful link

Inflammation is implicated in the pathogenesis of the dystrophinopathies despite the fact that most biopsies in patients with Duchenne muscular dystrophy do not show inflammatory cells. Corticosteroids have been used for more than 40 years with some success to treat patients with Duchenne muscular dystrophy. The central role of inflammation in the pathogenesis of the dystrophinopathies is suggested by the fact that use of corticosteroids, such as prednisone, results in prolongation of ambulation, maintenance of strength and function, and delay in the development of scoliosis. The side effects are well-known and do temper many clinicians enthusiasm to recommend its use in small children, patients with behavior or learning issues, or any patient for chronic use. A detailed understanding of the mechanism of action for corticosteroids on the body is still a large mystery.

To date, corticosteroids are the only medication that has demonstrated a modest benefit in modifying the course of the disease.[5] Clinical improvement is seen as early as 1 month after starting treatment and lasts as long as 3 years. Children who discontinue corticosteroids for various reasons soon revert to natural downward progression of the disease. It is hypothesized that prednisone reduces tissue inflammation, suppresses cytotoxic cells, improves calcium homeostasis, and stimulates myoblasts.

--Lisa Xiao 16:45, 31 August 2011 (EST)




Clarification on components of the assignment

  • If we find papers/books/info relating to another section that isn't ours, clearly write the name of the person it goes to and link/mention it e.g. Lisa: xyz

(this will just make it really easy to find)

  • When we have the majority of the info up, we can meet and format the page, as well as edit it to make it flow.
  • Keep checking this page for updates! Make this the main communication method between us, so keep an eye on it :D
  • We also agreed that any updates will be here at the bottom of the page, just makes the flow easier. So keep updates down here!!

Sections:

Jo: intro/history/epidemiology

Ashleigh: genetic component/aetiology/pathogenesis (close work with Rhiannon)

Rhiannon: signs and symptoms/clinical manifestations/pathogenesis/CASE STUDY 1 (close work with Ashleigh)

Lisa: Diagnosis/treatment/futher research and directions/CASE STUDY 2

  • Also, do we want to write anything about Becker's syndrome (the milder version of DMD?) Maybe we could do a comparison table if we can be bothered?

--Rhiannon Bice 13:02, 1 September 2011 (EST)


Hey guys, during my own research I've come across a lot of resources that each of you could use. They are only suggestions, but a few look really good!! I just thought I'd put them here to help us all along instead of you starting from scratch. I've spent most of today researching so its a bit of a waste if I don't pass it on :)

  • Lisa: http://www.sciencedirect.com/science/article/pii/0959437X9180033I. There is also a book at the library called "Myoblast Transfer Therapy" written by the Muscular Dystrophy Association that you may find useful. It can be found at the library at Level 8, Main Library (MB 617.4730592/1). Also, I used a lot information found in the paper at {http://onlinelibrary.wiley.com/doi/10.1002/mus.22097/full}, so this may be a good starting point for treatment, especially about problems relating to the cardiac/respiratory systems. They also give some good info on the treatments available. Basically, you will get a lot out of that paper! If you can't download it properly, buzz me your email and I'll send it to you.
  • Jo: Book called The history of a genetic disease : Duchenne muscular dystrophy or Meryon's disease Level 8, Main Library (MB 616.748/6). I think also when we all have our info about the actual disease written it will be heaps easier to write the introduction.
  • I have found a tonne of papers as well, so if everyone puts up their emails I can send it to you all. Even if you get one good sentence to use out of the whole paper then thats great!

-Chamberlain, J. (2007), "Duchenne Muscular Dystrophy", in Dunn, B. (ed.), Protein Epidemiology: Diseases at the Level of Protein Structure and Function, The Biomedical & Life Sciences Collection, London (online at http://hstalks.com/bio)

Ashleigh's writing - maybe use?: Normal functioning of Dystrophin verses impaired functioning

Dystrophin is part of a group of proteins found in skeletal and cardiac muscle that work to protect and strengthen muscles fibers as they contract and relax upon movement. Dystrophin also functions in connecting muscle cell’s with other proteins and molecules in order to send and receive chemical signals amongst cells and to anchor muscle fibers. [1]

Skeletal and cardiac muscle cells of Duchennes patients have no functional dystrophin present and therefore the muscle fibers become extensively damaged as they contract and relax with use. Overtime, these damaged cells weaken and eventually die resulting in multiple health implications. [2]


---Rhiannon.

  1. U.S. National Library of Medicine (2011). “Duchenne and Becker muscular dystrophy”. Author unknown, Genetics Home Reference. Accessed via http://ghr.nlm.nih.gov/condition/duchenne-and-becker-muscular-dystrophy
  2. U.S. National Library of Medicine (2011). “Duchenne and Becker muscular dystrophy”. Author unknown, Genetics Home Reference. Accessed via http://ghr.nlm.nih.gov/condition/duchenne-and-becker-muscular-dystrophy